The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022.
Where this comes from
- Record sourced from PubMed, PMID 36184631.
- Also identified by DOI 10.1038/s41467-022-33549-6 and PMC identifier 9526810.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Currently approved COVID vaccines are designed using the spike antigen derived from the ancestral strain, but health authorities are recommending changes to the vaccine strain to combat emerging variants. The goal is to ensure that next generation vaccines can tackle multiple variants of concern including the most prevalent variant for the coming season. We here discuss recent preclinical and clinical data on COVID vaccine antigens that are potential candidates for an updated vaccine.
Medical subject headings
- COVID-19
- Vaccines